ON Accelerate 9 Showcase
The Future of Deep Tech is here
The journey began in November 2024 with Bootcamp, where Australia’s brightest DeepTech innovators took their first steps toward commercialisation.
Following a highly competitive selection process, 11 standout teams advanced to Immersion Week and participated in the ON Core event in February 2025.
Over a period of three months, they will undergo an intensive program combining in-person and online learning, guided by industry experts and mentors.
On Thursday, 5 June 2025, we will celebrate the growth and achievements of these pioneering research-driven startups as they take the stage at the ON Accelerate 9 Showcase in Melbourne—presenting their ventures to investors, industry leaders, and the broader innovation ecosystem.
Don’t miss your chance to support the future of Australian innovation— register to attend the ON Accelerate 9 Showcase.
3DCeraFlex, from James Cook University, has developed patented technology for 3D printing flexible ceramic solutions, revolutionising high-temperature, defence, and energy applications. Currently working with AIMS to develop ceramic solutions for reef collaboration.
Ability Optics, an Australian National University spin out, focused on accelerating drug development. It has patented imaging hardware that enables faster and more cost-effective cell and tissue microscopy techniques, quickening the time-to-market for new personalised medicines.
Amorfoil, from CSIRO developed a patented planar flow casting process to create cost-competitive, efficient materials for grid distribution and electric vehicles.
Elemental Therapeutics, from The University of Melbourne, is restoring the efficacy of antibiotics against drug-resistant infections through the development of PBT2, a small molecule therapeutic for community-acquired bacterial pneumonia.
Enhanced Analgesics, from the University of Sydney, is addressing the global chronic pain crisis by developing a non-opioid drug that provides 24-28 hours of effective pain relief, offering a sustainable breakthrough alternative for millions suffering.
Epiblox, from the University of South Australia, is developing a breakthrough treatment for severe childhood epilepsy. Its lead drug candidate holds life-changing potential and strong commercial viability.
Facet Amtech, an SME licensing technology from the University of Newcastle, is revolutionising ammonia production with a breakthrough technology that improves energy efficiency, reducing the need for carbon-intensive natural gas.
I-VADE, from Edith Cowan University and in partnership with Alpha Immersion, is addressing rising violence in healthcare with an innovative VR-based aggression de-escalation training solution, improving overall staff and patient care.
Topicure, from RMIT University, is developing gel-based formulations to improve the delivery of active compounds through the skin, reducing side effects and increasing compliance for patients.
Viortec, an SME spun out of the Australian National University, is developing innovative devices for hip and knee replacement surgeries, enhancing surgical precision, supporting surgeons and improving patient outcomes.